Structure of the periplasmic component of a bacterial drug efflux pump

Proceedings of the National Academy of Sciences of the United States of America
Matthew K HigginsVassilis Koronakis

Abstract

Multidrug resistance among Gram-negative bacteria is conferred by three-component membrane pumps that expel diverse antibiotics from the cell. These efflux pumps consist of an inner membrane transporter such as the AcrB proton antiporter, an outer membrane exit duct of the TolC family, and a periplasmic protein known as the adaptor. We present the x-ray structure of the MexA adaptor from the human pathogen Pseudomonas aeruginosa. The elongated molecule contains three linearly arranged subdomains; a 47-A-long alpha-helical hairpin, a lipoyl domain, and a six-stranded beta-barrel. In the crystal, hairpins of neighboring MexA monomers pack side-by-side to form twisted arcs. We discuss the implications of the packing of molecules within the crystal. On the basis of the structure and packing, we suggest a model for the key periplasmic interaction between the outer membrane channel and the adaptor protein in the assembled drug efflux pump.

References

Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
Jan 8, 1999·Journal of Molecular Biology·H I Zgurskaya, H Nikaido
Jun 23, 1999·Proceedings of the National Academy of Sciences of the United States of America·H I Zgurskaya, H Nikaido
Aug 10, 2000·Molecular Microbiology·H I Zgurskaya, H Nikaido
Jan 12, 2001·Journal of Molecular Biology·C R CalladineB Luisi
Mar 28, 2001·EMBO Reports·C AndersenV Koronakis
Oct 6, 2001·Current Opinion in Microbiology·K Poole
Aug 7, 2002·Proceedings of the National Academy of Sciences of the United States of America·Christian AndersenVassilis Koronakis
Sep 28, 2002·Acta Crystallographica. Section D, Biological Crystallography·Thomas R Schneider, George M Sheldrick
Oct 11, 2002·Nature·Satoshi MurakamiAkihito Yamaguchi
Dec 17, 2002·The Journal of Biological Chemistry·M Ines Borges-WalmsleyAdrian R Walmsley
Aug 21, 2003·Biochemical and Biophysical Research Communications·Shin-ichiro NaritaTaiji Nakae
Sep 2, 2003·Current Opinion in Structural Biology·Satoshi Murakami, Akihito Yamaguchi
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4

❮ Previous
Next ❯

Citations

Aug 1, 2007·European Biophysics Journal : EBJ·Sylvain TrépoutOlivier Lambert
Oct 15, 2011·Applied Microbiology and Biotechnology·Silvia BazziniGiovanna Riccardi
Jan 17, 2012·Protoplasma·Victoria G LewisChristopher A McDevitt
Sep 1, 2005·Journal of Industrial Microbiology & Biotechnology·Simon Silver, Le T Phung
Sep 15, 2005·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Gregor GrassDietrich H Nies
Jun 9, 2005·Advanced Drug Delivery Reviews·Ayush Kumar, Herbert P Schweizer
Jun 14, 2005·Biochimie·Béatrice Marquez
Apr 2, 2013·Research in Microbiology·Kerstin KanonenbergLutz Schmitt
Jul 22, 2011·ACS Applied Materials & Interfaces·Lin WangChengzhi Cai
Dec 13, 2006·Nature Reviews. Drug Discovery·Olga LomovskayaWilliam J Watkins
Apr 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Martyn F SymmonsVassilis Koronakis
May 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Klaas M Pos
Jun 11, 2010·Proceedings of the National Academy of Sciences of the United States of America·Fabien De AngelisGuy Vandenbussche
Sep 16, 2011·The Journal of Biological Chemistry·Peter StaronIris Maldener
Mar 14, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Feng LongEdward W Yu
Mar 2, 2006·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Hiroyuki AkamaTaiji Nakae
May 6, 2008·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Shunfu PiaoNam Chul Ha
Jul 4, 2009·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Yongbin XuNam-Chul Ha
Jul 14, 2010·Journal of Gastroenterology and Hepatology·Kenro HirataToshifumi Hibi
Aug 5, 2008·Antimicrobial Agents and Chemotherapy·Makoto SugimuraTaiji Nakae
Apr 28, 2005·Antimicrobial Agents and Chemotherapy·Rungtip ChuanchuenHerbert P Schweizer
Apr 15, 2006·Clinical Microbiology Reviews·Laura J V Piddock
May 20, 2005·Journal of Bacteriology·Muriel MasiElizabeth Pradel
Sep 17, 2005·Journal of Bacteriology·Corinna BleuelGregor Grass
Mar 4, 2005·Journal of Bacteriology·Olga Lomovskaya, Maxim Totrov
Jun 7, 2008·Microbiology and Molecular Biology Reviews : MMBR·Amy L DavidsonJue Chen
Jul 3, 2013·Annual Review of Microbiology·Philip HinchliffeVassilis Koronakis
Feb 24, 2009·Annual Review of Biochemistry·Hiroshi Nikaido

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.